OxSonics Therapeutics logo — Tackling the toughest cancers.

OxSonics Therapeutics

Tackling the toughest cancers.

Founded 2013 United Kingdom United Kingdom 17 employees Series B Total: $24.70M Biotechnology, Medical Devices

General Information

Company Name OxSonics Therapeutics
Founded Year 2013
Location United Kingdom United Kingdom +1
Employees 17
Industries Biotechnology, Medical Devices
Funding Stage Series B
Social

Get notified when OxSonics Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OxSonics Therapeutics

OxSonics Therapeutics is a UK-based startup that is pioneering a ground-breaking platform technology to make anti-cancer drugs smarter, faster, and more effective. Their SonoTran® Platform has been designed to actively enhance the delivery of oncology drugs into solid tumors. The platform is drug agnostic and requires no drug reformulation, allowing its use with both existing and novel therapies. Established in 2013, the company is active in the Biotechnology and Medical Devices industries. In July 2020, OxSonics secured a significant £10.50M in Series B investment, demonstrating strong investor confidence in its technology and potential. The company also has collaborations with pharmaceutical and biotech companies to bring smarter, faster, and better therapies to a larger patient group. With its slogan "Tackling the toughest cancers," OxSonics Therapeutics is at the forefront of developing innovative solutions to combat cancer.

Taxonomy: Oncology, Drug Delivery, Cancer Therapeutics, SonoTran Platform, Clinical-stage Therapeutics, Solid Tumour Cancers, Drug Delivery Platform, Biomedical Engineering, Pharmaceutical Collaborations, Biotech Collaboration, Patient Treatment, Clinical Workflows, Real-time Visualization

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• - 01 Jul 2020
Series B •••••• 5
Investor Investor Investor Investor
•••• ••••
07 Jan 2017
Grant •••••• 1
Investor
16 Jun 2014
Series A •••••• - 08 Jan 2014

OxSonics Therapeutics Alternatives & Competitors

OxSonics Therapeutics vs

Putting Patients First, Innovation for All

Series C
1 employees
Biopharma, Biotechnology
OxSonics Therapeutics vs

Innovative solutions for precise MRI imaging and cancer treatment with advanced drug delivery and li...

Series Unknown
1 employees
Biotechnology, Life Sciences
OxSonics Therapeutics vs

SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing breakthrough cancer...

Series Unknown
8 employees
Biotechnology, Life Sciences

FAQ About OxSonics Therapeutics

Tackling the toughest cancers.
OxSonics Therapeutics was founded in 2013.
OxSonics Therapeutics is headquartered in United Kingdom.
OxSonics Therapeutics operates in the following industries: Biotechnology, Medical Devices.
OxSonics Therapeutics has approximately 17 employees.
OxSonics Therapeutics has completed 4 funding rounds, raising a total of $24.70M. The latest funding stage is Series B.
Top alternatives and competitors to OxSonics Therapeutics include Beihai Biotech, Photobiotics, SciTech Development, Inc., Cairn Biosciences, Rexis Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OxSonics Therapeutics and Beihai Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OxSonics Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy